Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

Mounjaro, a newly launched weight-loss and diabetes drug, is now available in India. Developed by Eli Lilly, it promises more effectiveness than Ozempic and comes at a lower cost. Experts believe it ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.

A single-dose vial of Mounjaro costs Rs. 3,500 for 2.5 mg or Rs. 4,375 for 5 mg. On a typical weekly dose, that adds up to ...

Zerodha’s Nithin Kamath sparks debate on Ozempic, Mounjaro & their game-changing impact on obesity, addiction & industries. Is India ready for this shift?

Tata Capital is looking to go public with a mega IPO issue size of around ₹15,000 crore, which will be combined of fresh ...

Mounjaro, a prescription-only weight management and diabetes drug, costs ₹14,000–₹17,500 monthly in India. While effective, ...

Kamath flagged that most of the world — including India — still doesn’t fully understand the long-term impact of these drugs.

While medications provide temporary weight-loss solutions, experts stress lifestyle changes as the most effective way to ...

In the latest episode of Blueprint Explosive Exclusive, Meghna Deka discusses Harbhajan Singh's 'Kaali Taxi' Remark on Jofra ...

In the latest episode of Blueprint Explosive Exclusive, Madhavdas GK discusses row over Karnataka Deputy CM DK Shivakumar's ...